While rare diseases often get left behind in the race for cures, a new approach from the National Institutes of Health hopes to make clinical trials more efficient, less expensive, and more accessible to patients who are suffering from rare genetic diseases. WBZ's Laurie Kirby spoke with Dr. Julie Gerberding, CEO of the Foundation for the National Institutes of Health, about the new "Bespoke" Consortium.

See omnystudio.com/listener for privacy information.